日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary End Points

恩扎卢胺单药治疗高危生化复发的前列腺癌：EMBARK 次要终点

期刊:Journal of Urology
影响因子:6.8
doi:10.1097/JU.0000000000004879
Shore, Neal D; De Giorgi, Ugo; Tutrone, Ronald F; Bailen, James L; Roos, Erik P M; Kliment, Ján; Marx, Gavin; Karsh, Lawrence I; Ramirez-Backhaus, Miguel; Uchio, Edward M; Supiot, Stéphane; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J
肿瘤
前列腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARK

根据欧洲泌尿外科协会的定义，恩扎卢胺用于高危生化复发性前列腺癌患者：EMBARK 研究的事后分析

期刊:Prostate Cancer and Prostatic Diseases
影响因子:5.8
doi:10.1038/s41391-025-00959-8
De Giorgi, Ugo; Freedland, Stephen J; Rannikko, Antti; Ramirez-Backhaus, Miguel; Villers, Arnauld; Tarazi, Jamal; Tang, Yiyun; Haas, Gabriel P; Rosales, Matt; Shore, Neal D
肿瘤
前列腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration

肾功能损害对静脉注射普地沙西尼铵（ASP5354）后药代动力学、安全性和耐受性的影响：一项机制研究

期刊:European Journal of Clinical Pharmacology
影响因子:2.7
doi:10.1007/s00228-026-04063-1
Kojima, Tomoki; Saito, Masako; Matsuda, Toshihiro; Simmons, Neal; Nagata, Masanori; Miyagawa, Mayuko; Wojtkowski, Tomasz; Guro, Sayuri; Koibuchi, Akira; Cruz, Kimberly S; Neutel, Joel M; Free, Almena L; Sekino, Hisakuni; Haas, Gabriel P; Takusagawa, Shin
P53
发表日期：2026
文献求助 收藏

Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review

恩扎卢胺治疗晚期前列腺癌患者（涵盖疾病谱）：简明语言综述

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2475730
Dato, Paul E; De La Cerda, Jose; Armstrong, Andrew J; Azad, Arun A; Conduit, Ciara; Haas, Gabriel P; Kernen, Kenneth; Klaassen, Zachary W; Patel, Raj; Saad, Fred; Shore, Neal D; Freedland, Stephen J; Karsh, Lawrence I
肿瘤
前列腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial

恩扎卢胺和前列腺特异性抗原水平在转移性前列腺癌中的作用：ARCHES随机临床试验的二次分析

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.8751
Azad, Arun A; Petrylak, Daniel P; Iguchi, Taro; Shore, Neal D; Villers, Arnauld; Gomez-Veiga, Francisco; Alcaraz, Antonio; Alekseev, Boris; Szmulewitz, Russell Z; Holzbeierlein, Jeffrey; Rosbrook, Brad; Ma, Jie; Zohren, Fabian; El-Chaar, Nader N; Haas, Gabriel P; Stenzl, Arnulf; Armstrong, Andrew J
ARC
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Plain language summary: does enzalutamide treatment with or without leuprolide improve outcomes and affect quality of life in patients with high-risk biochemical recurrence?

简明语言摘要：恩扎卢胺联合或不联合亮丙瑞林治疗能否改善高危生化复发患者的预后并影响其生活质量？

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2024.2426425
Freedland, Stephen J; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M; Tutrone, Ronald F Jr; Venugopal, Balaji; Woo, Henry H; Ramirez-Backhaus, Miguel; Tarazi, Jamal; Tang, Yiyun; Ganguli, Arijit; Haas, Gabriel P; Shore, Neal D
发表日期：2025
文献求助 收藏

Enzalutamide in metastatic hormone-sensitive prostate cancer: A plain language summary of the ARCHES and ENZAMET follow-up studies

恩扎卢胺治疗转移性激素敏感性前列腺癌：ARCHES 和 ENZAMET 随访研究的简明摘要

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2024.2408101
Armstrong, Andrew J; Azad, Arun A; Conduit, Ciara; Haas, Gabriel P; Bland, Christopher; Davis, Ian D
肿瘤
MET
肿瘤免疫
ARC
前列腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

MyoQuant: An optimized image analysis algorithm for quantitative analysis of skeletal muscle fibers

MyoQuant：一种用于骨骼肌纤维定量分析的优化图像分析算法

期刊:MethodsX
影响因子:1.9
doi:10.1016/j.mex.2025.103645
Madsen, Josh; Haas, Gabriel; Dunn, Andrew; Ziemkiewicz, Natalia; Johnson, David; Garg, Koyal
发表日期：2025
文献求助 收藏

Reliability of Likert Scale for Surgeon-Rated Conspicuity of Ureters with Pudexacianinium Chloride (ASP5354)

李克特量表对外科医生评估的输尿管显影情况（使用普地西氰铵氯化物）的可靠性（ASP5354）

期刊:Jsls-Journal of the Society of Laparoendoscopic Surgeons
影响因子:1.8
doi:10.4293/JSLS.2024.00069
Atzinger, Chris; Dickerson, Heather; Polek, Ela; Otto, Christiane; Gao, Yanli; Liu, Lin; Kumar, Anil; Haas, Gabriel P
P53
发表日期：2025
文献求助 收藏

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

CAR-iNKT 的抗骨髓瘤疗效可通过长效 IL-7（rhIL-7-hyFc）增强。

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023010032
O'Neal, Julie; Cooper, Matthew L; Ritchey, Julie K; Gladney, Susan; Niswonger, Jessica; González, L Sofía; Street, Emily; Haas, Gabriel J; Carter, Alun; Amayta, Parmeshwar N; Gao, Feng; Lee, Byung Ha; Choi, Donghoon; Berrien-Elliott, Melissa; Zhou, Alice; Fehniger, Todd A; Rettig, Mike P; DiPersio, John F
IL-7
骨髓瘤
发表日期：2023
文献求助 收藏